Skip to main content
Icure Pharmaceutical Incorporation logo

Icure Pharmaceutical Incorporation — Investor Relations & Filings

Ticker · 175250 ISIN · KR7175250000 KO Manufacturing
Filings indexed 317 across all filing types
Latest filing 2026-04-20 Annual Report
Country KR South Korea
Listing KO 175250

About Icure Pharmaceutical Incorporation

https://www.icure.co.kr/eng/

Icure Pharmaceutical Incorporation is a biopharmaceutical company that researches, develops, manufactures, and commercializes high-tech drug products. The company's core expertise lies in its Transdermal Drug Delivery System (TDDS) technology, which facilitates 'Cure & Care' solutions through the skin. Its portfolio includes both pharmaceutical products, such as NSAIDS patches, and cosmetic lines developed with a pharmaceutical and medical foundation. Icure focuses on creating innovative formulations and drug delivery systems to improve therapeutic outcomes and patient convenience.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for the company 'Icure Pharmaceutical' (아이큐어 주식회사). It contains detailed financial data, management discussions, corporate governance information, and operational details for the fiscal year ending December 31, 2025. It is a comprehensive annual filing submitted to the Financial Services Commission and Korea Exchange. Although it is labeled as a 'correction' (정정신고), it constitutes the full annual report filing, not merely an announcement of one. FY 2025
2026-04-20 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a standalone auditor’s report (“감사보고서”) issued by an external audit firm on the consolidated financial statements of 아이큐어주식회사 for the year ended December 31, 2025. It contains the auditor’s opinion, basis of opinion, key audit matters, and the full set of audited consolidated financial statements with notes. This matches the definition of an Audit Report / Information (AR), not an Annual Report or a simple announcement. FY 2025
2026-04-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the results of the 26th Annual General Meeting held on 2026-03-31, detailing voting outcomes for each agenda item (approval of financial statements, amendments, director appointments, etc.). This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a Korean-language disclosure titled “감사보고서 제출” (Audit Report Submission) containing the auditor’s opinions on consolidated and separate financial statements, key financial metrics for current and prior fiscal years, and audit-related notes. It is not a full annual report (10-K/Annual Report) but rather the standalone audited financials and auditor’s opinion. This matches the definition for an Audit Report / Information filing. FY 2025
2026-03-30 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the solicitation of proxies for a general meeting of shareholders, including voting methods (electronic/written), the purpose of the meeting, and the agenda items. It is a formal document sent to shareholders to request their votes, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-19 Korean
사업보고서제출기한연장신고서 (2025.12)
Regulatory Filings Classification · 1% confidence The document is a formal 'Report Submission Deadline Extension' (사업보고서제출기한연장신고서) filed by Icure Co., Ltd. to the Financial Services Commission and the Korea Exchange. It explains that the company cannot meet the statutory deadline for filing its annual report due to delays in the audit process, as confirmed by the external auditor. Since this is a regulatory notification regarding the timing and status of a report filing rather than the annual report itself, it falls under the category of regulatory filings.
2026-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.